Zhang Yafei elected as member of the 14th batch of national Recruitment Program of Global Expert
Dr. Zhang Yafei from Kaijie(Suzhou) Translational Medicine Research Co., Ltd. was on the just released list of the 14th batch of national Recruitment Program of Global Expert.
Dr. Zhang Yafei
Dr. Zhang Yafei, boasting above 25-year experience in medicine R&D, is the chairman of the board and CEO of Kaijie(Suzhou) Translational Medicine Research Co., Ltd.
Kaijie(Suzhou) is a technical innovation company which provides bio-marker validation, companion diagnostics development, clinical test services and other complete precision medical treatment solutions. Dr. Zhang was the Chinese Market General Manager and Senior Vice President of Frontage laboratories, Inc. He was also department director of Novartis China R&D Center. Before returning to China, he was department director of OSI and manager of Pfizer Global R&D, researched and applied 6 IND and 1 NDA/MAA drugs for marketing. He served FDA’s product quality and research committee on behalf of Pfizer, and China Food and Drug Administration’s work committee on behalf of Novartis. Before going abroad, Dr. Zhang worked in the Institute of Applied Chemistry, Chinese Academy Of Sciences, and then graduated from University of Cincinnati and earned his drug analysis doctorate there in 1995 .
Dr. Zhang is a member of Bayhelix, an organization of Chinese elite from global life science, medical and health industry. He is also the vice president of Biotechnology Association of Jiangsu, director member of Biotechnology Committee of Sino-EU Chemical Manufacturers Association, one of the founders and vice director member of Precision Medical Treatment and Companion Diagnostics Professional Committee of Chinese Society of Biotechnology. He was honored SIP Startup and Innovation Leading Talent, Jinji Lake Two 100-Talent, Jiangsu Provincial Startup and Innovation Talent, Jiangsu Overseas High-level Talent, Jiangsu Outstanding Entrepreneurs and included in National Recruitment Program of Global Expert of the Organization Department of the Central Committee of the CPC.
Kaijie(Suzhou) Translational Medicine Research Co., Ltd.
Kaijie(Suzhou) Translational Medicine Research Co., Ltd. is an innovative company which provides complete solutions for precision medical treatment. Relying on Qiagen and other advanced instruments, agent platforms and its powerful technical team, Kaijie(Suzhou) can provide one-stop services from biomarker discovery and detection method development to new drug clinical test, patient’s molecular tests and grouping screening and companion diagnostics agent development and commercialization for its partners. We hope to team up with you to leverage Kaijie’s advanced nucleic acid and protein diagnostics technology and translational medicine knowledge and experience to accelerate the clinical development of new drugs and provide individualized clinical and treatment solutions for the urgent medical treatment demand in Chinese market.